News

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
UPI4mon
FDA approves Spravato, first monotherapy nasal spray to treat depression
Johnson & Johnson's Spravato ... oral antidepressants," Martin added. The FDA approval of Spravato comes after a controlled study showed the nasal spray provided rapid improvement in the ...
Hosted on MSN4mon
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults ... new major depression treatment to win FDA approval in more than three decades.
NBC New York4mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in ... new major depression treatment to win FDA approval in more than three decades.